Cyclerion Therapeutics (CYCN) Stock Chart & Stock Price History $3.30 +0.01 (+0.15%) As of 07/3/2025 02:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cyclerion Therapeutics Stock Price Performance The Cyclerion Therapeutics (CYCN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 46.89%, with a year-to-date return of 2.64%. In the past month, the stock has increased 5.59%, reflecting recent market activity. As of the latest close, Cyclerion Therapeutics traded at $3.31 with a market cap of $10.61 million and volume of 19,378 shares. Five years ago, the stock traded at a split-adjusted price of $116.00, representing a 97.15% decrease over that period. At the time, it had a market cap of $160.12 million and a volume of 7,805 shares. Receive CYCN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.94%1 Month Performance+5.59%3 Month Performance+32.20%Year-To-Date Performance+2.64%1 Year Performance+46.89%5 Year Performance-97.15% CYCN Stock Chart for Friday, July, 4, 2025 CYCN Chart by TradingView Cyclerion Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$3.30$3.31+0.15%$3.43$3.0619,378 shs$10.61 million07/02/2025$3.10$3.30+6.45%$3.50$3.11141,823 shs$10.59 million07/01/2025$2.91$3.10+6.53%$3.15$2.858,895 shs$9.95 million06/30/2025$2.98$2.91-2.32%$2.99$2.7522,115 shs$9.34 million06/27/2025$2.81$2.98+6.01%$3.22$2.7195,446 shs$9.56 million06/26/2025$2.94$2.81-4.26%$3.04$2.7177,408 shs$9.02 million06/25/2025$3.00$2.94-2.17%$3.07$2.814,072 shs$9.42 million06/24/2025$2.88$3.00+4.17%$3.13$2.879,761 shs$9.63 million06/23/2025$2.95$2.88-2.37%$3.14$2.888,643 shs$9.25 million06/20/2025$3.15$2.95-6.35%$3.16$2.9517,413 shs$9.47 million Get the Latest News and Ratings for CYCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$3.15$3.15$3.15$3.043,302 shs$10.11 million06/18/2025$3.11$3.15+1.29%$3.15$3.043,302 shs$10.11 million06/17/2025$3.11$3.11+0.16%$3.13$3.0212,129 shs$9.98 million06/16/2025$3.11$3.11-0.16%$3.11$3.064,305 shs$9.97 million06/13/2025$3.10$3.11+0.32%$3.19$2.939,411 shs$9.98 million06/12/2025$3.13$3.10-0.80%$3.18$2.9216,196 shs$9.95 million06/11/2025$3.14$3.13-0.48%$3.20$2.9413,719 shs$10.03 million06/10/2025$3.14$3.14$3.31$3.119,214 shs$10.08 million06/09/2025$3.18$3.14-1.26%$3.25$3.0810,274 shs$10.08 million06/06/2025$3.17$3.18+0.32%$3.19$3.0415,140 shs$10.21 million06/05/2025$3.13$3.17+1.28%$3.26$3.018,851 shs$10.18 million06/04/2025$3.20$3.13-2.19%$3.25$3.0120,347 shs$10.05 million06/03/2025$2.96$3.20+8.11%$3.29$2.8048,250 shs$10.27 million Related Companies KPTI Stock Chart ATHE Stock Chart ACRV Stock Chart VOR Stock Chart EGRX Stock Chart AKTX Stock Chart ELYM Stock Chart ESLA Stock Chart XLO Stock Chart LVTX Stock Chart Receive CYCN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCN) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclerion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclerion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
